• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙戊酸盐治疗儿童失神癫痫:剂量反应关系研究

Valproate in the treatment of absence epilepsy in children: a study of dose-response relationships.

作者信息

Braathen G, Theorell K, Persson A, Rane A

机构信息

Department of Pediatrics, Karolinska Institute, Huddinge University Hospital, Sweden.

出版信息

Epilepsia. 1988 Sep-Oct;29(5):548-52. doi: 10.1111/j.1528-1157.1988.tb03759.x.

DOI:10.1111/j.1528-1157.1988.tb03759.x
PMID:3137019
Abstract

Seven children with absence epilepsy were treated with valproate (VPA). All but one child became free of absence seizures during VPA monotherapy. EEG was recorded for 24 h before start of VPA treatment and repeatedly during treatment. Correlation between plasma VPA concentration and reduction of the number of epileptic discharges was significant. Plasma concentration of 440-660 microM VPA was needed to achieve at least 50% reduction of seizure activity.

摘要

七名失神癫痫患儿接受了丙戊酸盐(VPA)治疗。除一名患儿外,其他所有患儿在VPA单药治疗期间均无失神发作。在开始VPA治疗前记录了24小时脑电图,并在治疗期间多次记录。血浆VPA浓度与癫痫放电次数减少之间存在显著相关性。需要440 - 660微摩尔/升的血浆浓度才能使癫痫活动至少减少50%。

相似文献

1
Valproate in the treatment of absence epilepsy in children: a study of dose-response relationships.丙戊酸盐治疗儿童失神癫痫:剂量反应关系研究
Epilepsia. 1988 Sep-Oct;29(5):548-52. doi: 10.1111/j.1528-1157.1988.tb03759.x.
2
Fluctuating and constant valproate administration gives equivalent seizure control in rats with genetic and acquired epilepsy.波动和持续给药丙戊酸钠在遗传性和获得性癫痫大鼠中具有等效的抗癫痫作用。
Seizure. 2011 Jan;20(1):72-9. doi: 10.1016/j.seizure.2010.10.011. Epub 2010 Nov 18.
3
Lamotrigine versus valproic acid as first-line monotherapy in newly diagnosed typical absence seizures: an open-label, randomized, parallel-group study.拉莫三嗪与丙戊酸作为新诊断的典型失神发作一线单药治疗的比较:一项开放标签、随机、平行组研究。
Epilepsia. 2004 Sep;45(9):1049-53. doi: 10.1111/j.0013-9580.2004.40903.x.
4
[Valproic acid versus lamotrigine as a monotherapy for absence epilepsy in children].丙戊酸与拉莫三嗪作为儿童失神癫痫单一疗法的比较
Zhongguo Dang Dai Er Ke Za Zhi. 2009 Aug;11(8):653-5.
5
[Valproic acid -- clinical efficiency and serum concentration in the treatment of petit mal epilepsy in childhood (author's transl)].丙戊酸——儿童失神癫痫治疗中的临床疗效与血清浓度(作者译)
Padiatr Padol. 1981;16(4):481-8.
6
Absence seizures: valproate or ethosuximide?失神发作:丙戊酸盐还是乙琥胺?
Acta Neurol Scand Suppl. 1983;97:41-8. doi: 10.1111/j.1600-0404.1983.tb01534.x.
7
Ethosuximide, sodium valproate or lamotrigine for absence seizures in children and adolescents.乙琥胺、丙戊酸钠或拉莫三嗪用于儿童及青少年失神发作。
Cochrane Database Syst Rev. 2003(3):CD003032. doi: 10.1002/14651858.CD003032.
8
Low-dose sodium valproate in the treatment of idiopathic generalized epilepsies.低剂量丙戊酸钠治疗特发性全面性癫痫。
Acta Neurol Scand. 2014 May;129(5):e20-3. doi: 10.1111/ane.12216. Epub 2013 Dec 24.
9
Clinical and pharmacokinetic observations on sodium valproate - a 5-year follow-up study in 100 children with epilepsy.丙戊酸钠的临床和药代动力学观察——对100例癫痫患儿的5年随访研究
Acta Neurol Scand. 1982 May;65(5):504-23. doi: 10.1111/j.1600-0404.1982.tb03106.x.
10
Effect of valproic acid on spike and wave discharges in patients with absence seizures.丙戊酸对失神发作患者棘波和慢波放电的影响。
Neurology. 1978 Sep;28(9 Pt 1):886-91. doi: 10.1212/wnl.28.9.886.

引用本文的文献

1
Population pharmacokinetics of valproic acid in children with epilepsy: Implications for dose tailoring when switching from oral syrup to sustained-release tablets.儿童癫痫患者丙戊酸的群体药代动力学:从口服糖浆切换至控释片时剂量调整的意义。
CPT Pharmacometrics Syst Pharmacol. 2024 Sep;13(9):1554-1569. doi: 10.1002/psp4.13191. Epub 2024 Jun 24.
2
Pharmacogenetics-based population pharmacokinetic analysis and dose optimization of valproic acid in Chinese southern children with epilepsy: Effect of gene polymorphism.基于药物遗传学的丙戊酸在中国南方癫痫儿童中的群体药代动力学分析及剂量优化:基因多态性的影响
Front Pharmacol. 2022 Nov 25;13:1037239. doi: 10.3389/fphar.2022.1037239. eCollection 2022.
3
Current Concepts in the Management of Idiopathic Generalized Epilepsies.
特发性全身性癫痫的管理现状
Ann Indian Acad Neurol. 2022 Jan-Feb;25(1):35-42. doi: 10.4103/aian.aian_888_21. Epub 2022 Feb 1.
4
Valproic Acid and Epilepsy: From Molecular Mechanisms to Clinical Evidences.丙戊酸与癫痫:从分子机制到临床证据。
Curr Neuropharmacol. 2019;17(10):926-946. doi: 10.2174/1570159X17666181227165722.
5
Valproate in children with newly diagnosed idiopathic generalized epilepsy.丙戊酸盐治疗新诊断的特发性全面性癫痫儿童。
Acta Neurol Scand. 2010 Mar;121(3):149-53. doi: 10.1111/j.1600-0404.2009.01308.x. Epub 2010 Jan 6.
6
Valproate: past, present, and future.丙戊酸盐:过去、现在与未来。
CNS Drug Rev. 2003 Summer;9(2):199-216. doi: 10.1111/j.1527-3458.2003.tb00249.x.
7
Pharmacological and therapeutic properties of valproate: a summary after 35 years of clinical experience.丙戊酸盐的药理和治疗特性:35年临床经验总结
CNS Drugs. 2002;16(10):695-714. doi: 10.2165/00023210-200216100-00004.
8
Clinical pharmacokinetics of antiepileptic drugs in paediatric patients. Part I: Phenobarbital, primidone, valproic acid, ethosuximide and mesuximide.抗癫痫药物在儿科患者中的临床药代动力学。第一部分:苯巴比妥、扑米酮、丙戊酸、乙琥胺和甲琥胺。
Clin Pharmacokinet. 1995 Oct;29(4):257-86. doi: 10.2165/00003088-199529040-00005.
9
Therapeutic drug monitoring of anticonvulsants. State of the art.抗惊厥药的治疗药物监测。最新进展。
Clin Pharmacokinet. 1990 Apr;18(4):318-28. doi: 10.2165/00003088-199018040-00004.